Fresenius SE KGaAXSWX:FRE 71 PS Ratio is 0.94 as of Jun. 24, 2026, which is 22% above its 10-year median of 0.77. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF32.85 (Fairly Valued). The stock has 5 warning signs investors should review. Among 663 Healthcare Providers & Services companies, Fresenius SE KGaA ranks better than 63.95% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Fresenius SE KGaA's share price is CHF35.86.
Fresenius SE KGaA's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was CHF38.04. Hence, Fresenius SE KGaA's PS Ratio for today is 0.94.
Good Sign:
Fresenius SE & Co KGaA stock PS Ratio (=0.97) is close to 1-year low of 0.89.
The historical rank and industry rank for Fresenius SE KGaA's PS Ratio or its related term are showing as below:
XSWX:FRE'
s PS Ratio Range Over the Past 10 Years
Min: 0.31 Med: 0.77 Max: 1.43
Current: 0.97
During the past 13 years, Fresenius SE KGaA's highest PS Ratio was 1.43. The lowest was 0.31. And the median was 0.77.
XSWX:FRE's PS Ratio is ranked better than 63.95% of 663
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs XSWX:FRE: 0.97
Fresenius SE & Co KGaA revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Fresenius SE KGaA was 3.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 1.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -10.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -4.10% per year.
During the past 13 years, Fresenius SE KGaA's highest 3-Year average Revenue per Share Growth Rate was 12.50% per year. The lowest was -26.00% per year. And the median was 4.80% per year.
Back to Basics: PS Ratio
Fresenius SE KGaA (XSWX:FRE) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Fresenius SE KGaA PS Ratio Related Terms
Fresenius SE KGaA PS Ratio Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Fresenius SE KGaA's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's PS Ratio distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Fresenius SE KGaA's Share Price of today is CHF35.86. Fresenius SE KGaA's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF38.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Fresenius SE KGaA (XSWX:FRE) has a PS Ratio of 0.94 as of Jun. 24, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Fresenius SE KGaA and its competitors. This is 22% above median its historical median of 0.77. Over the past decade, Fresenius SE KGaA's PS Ratio has ranged from 0.31 to 1.43. According to the industry distribution chart, Fresenius SE KGaA ranks #239 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 36%.
Is Fresenius SE KGaA's PS Ratio too high?
Fresenius SE KGaA's current PS Ratio of 0.94 is 22% above median its 10-year median of 0.77. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 1.43. The Healthcare Providers & Services industry median PS Ratio is 1.47. Fresenius SE KGaA's value of 0.94 is 36.1% below this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #239 out of 663 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #239 out of 663 companies for PS Ratio. This puts Fresenius SE KGaA in the upper half of its industry. The industry median PS Ratio is 1.47. Fresenius SE KGaA's value of 0.94 is 36.1% below this benchmark. Historically, Fresenius SE KGaA's own PS Ratio has ranged from 0.31 to 1.43 over the past decade. While the company's 10-year median is 0.77 vs. the industry median of 1.47, Fresenius SE KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.47, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current PS Ratio of 0.94 is 36.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current PS Ratio is 0.94, which is 22% above median its own 10-year median of 0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF32.85, compared to a current price of CHF35.86 — trading 9.2% above its estimated fair value. The current PS Ratio is 0.94, which is 22% above median its 10-year median of 0.77 and 36.1% below the Healthcare Providers & Services industry median of 1.47. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current PS Ratio is 0.94 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF35.86 is trading 9.2% above its estimated GF Value™ of CHF32.85.
GuruFocus considers Fresenius SE KGaA to be Fairly Valued.
Key valuation signals for XSWX:FRE:
PS Ratio: 0.94 (22% above median its 10-year median of 0.77)
GF Value™: CHF32.85 vs. price of CHF35.86 (9.2% above fair value)
Industry Position: 36.1% below the Healthcare Providers & Services median (#239 of 663)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score
Get the complete analysis for XSWX:FRE
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 
